| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner, Director By Deputization | Director, 10% Owner, * Director By Deputization | 10% Owner +10 more
37 companies
Flynn James E is a 10% Owner, *possible Member Of 10% Group at AdaptHealth Corp. with holdings across 37 companies. Recent SEC Form 4 filings include 13 buys and 19 sells.
Estimated insider holdings value: $1840.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 24, 2025 | NUVL Nuvalent, Inc. | Director, 10% Owner, Director By Deputization | Sell | 742,574 | $95.45 | $70,874,975.43 | -4.3% | -6.0% | - | |
| Jul 31, 2025 | LRMR Larimar Therapeutics, Inc. | Director, 10% Owner, * Director By Deputization | Buy | 9,375,000 | $3.20 | $30,000,000.00 | +55.1% | +24.6% | - | |
| Jun 27, 2025 | SPRY Ars Pharmaceuticals, Inc. | 10% Owner | Sell | 740,149 | $18.46 | $13,663,150.54 | -7.0% | -47.6% | - | |
| Nov 12, 2024 | SPRY Ars Pharmaceuticals, Inc. | 10% Owner | Sell | 563,270 | $18.01 | $10,143,705.51 | -1.3% | -29.3% | -46.1% | |
| Oct 22, 2024 | NUVL Nuvalent, Inc. | Director, 10% Owner, * Director By Deputization | Sell | 2,000,000 | $97.75 | $195,500,000.00 | -10.3% | -23.6% | -11.3% | |
| Sep 17, 2024 | BCAX Bicara Therapeutics Inc. | 10% Owner, Possible Members Of 10% Group | Buy | 70,000 | $18.00 | $1,260,000.00 | +4.1% | -35.7% | -59.5% | |
| Mar 12, 2024 | AHCO Adapthealth Corp. | 10% Owner, *possible Member Of 10% Group | Sell | 350,000 | $10.90 | $3,815,703.53 | -0.6% | +1.4% | -12.0% | |
| Feb 16, 2024 | LRMR Larimar Therapeutics, Inc. | Director, 10% Owner, * Director By Deputization | Buy | 4,290,617 | $8.74 | $37,499,992.58 | +35.1% | -41.9% | -73.9% | |
| Nov 3, 2022 | NUVL Nuvalent, Inc. | Director, 10% Owner, Director By Deputization | Buy | 650,000 | $33.50 | $21,775,000.00 | New | -0.9% | +92.6% | |
| Sep 16, 2022 | LRMR Larimar Therapeutics, Inc. | Director, 10% Owner, * Director By Deputization | Buy | 11,111,108 | $3.15 | $34,999,990.20 | +190.6% | +42.5% | +32.5% |